{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:29:33Z","timestamp":1784323773530,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019992","name":"Australian Academy of Technological Sciences and Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jare.2023.04.001","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T18:02:12Z","timestamp":1681408932000},"page":"69-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["ENOX2 inhibition enhances infiltration of effector memory T-cell and mediates response to chemotherapy in immune-quiescent nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"56","author":[{"given":"Ngar-Woon","family":"Kam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0966-9897","authenticated-orcid":false,"given":"Olivier","family":"Laczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syrus Pak Hei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Wa","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-0685","authenticated-orcid":false,"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Ming","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Ho-Fun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora Lai-Wan","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10192","key":"10.1016\/j.jare.2023.04.001_b0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"issue":"9476","key":"10.1016\/j.jare.2023.04.001_b0010","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","article-title":"Nasopharyngeal carcinoma","volume":"365","author":"Wei","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jare.2023.04.001_b0015","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41467-021-21795-z","article-title":"Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma","volume":"12","author":"Gong","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jare.2023.04.001_b0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-021-21043-4","article-title":"Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2023.04.001_b0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"6754","key":"10.1016\/j.jare.2023.04.001_b0030","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jare.2023.04.001_b0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(01)00455-X","article-title":"Regulation of T cell immunity by dendritic cells","volume":"106","author":"Lanzavecchia","year":"2001","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jare.2023.04.001_b0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.20131271","article-title":"Memory CD8+ T cells exhibit increased antigen threshold requirements for recall proliferation","volume":"211","author":"Mehlhop-Williams","year":"2014","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.jare.2023.04.001_b0045","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.jare.2023.04.001_b0050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.jare.2023.04.001_b0055","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-04-2429","article-title":"Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1\/CIP1","volume":"65","author":"Aguero","year":"2005","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.jare.2023.04.001_b0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3727\/000000006783980973","article-title":"ECTO-NOX target for the anticancer isoflavene phenoxodiol","volume":"16","author":"Morre","year":"2007","journal-title":"Oncol Res"},{"issue":"4","key":"10.1016\/j.jare.2023.04.001_b0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2217\/14796694.4.4.475","article-title":"Anti-tumor activity of phenoxodiol: from bench to clinic","volume":"4","author":"Alvero","year":"2008","journal-title":"Future Oncol"},{"issue":"7","key":"10.1016\/j.jare.2023.04.001_b0070","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3324\/haematol.2008.003996","article-title":"The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells","volume":"94","author":"Herst","year":"2009","journal-title":"Haematologica"},{"issue":"9B","key":"10.1016\/j.jare.2023.04.001_b0075","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1111\/j.1582-4934.2009.00695.x","article-title":"Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo","volume":"13","author":"Georgaki","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.jare.2023.04.001_b0080","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.euo.2020.07.002","article-title":"Phase I\/II Trial of the Combination of (177)Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)","volume":"4","author":"Crumbaker","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.jare.2023.04.001_b0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2967\/jnumed.121.262552","article-title":"(177)Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I\/II Trial","volume":"63","author":"Pathmanandavel","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jare.2023.04.001_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2021.100631","article-title":"NOX66 as Monotherapy, and in Combination With Carboplatin, in Patients With Refractory Solid Tumors: Phase Ia\/b Study","volume":"94","author":"Kiknavelidze","year":"2021","journal-title":"Curr Ther Res Clin Exp"},{"issue":"4","key":"10.1016\/j.jare.2023.04.001_b0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01789334","article-title":"Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy","volume":"35","author":"Komada","year":"1992","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"10.1016\/j.jare.2023.04.001_b0100","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1182\/blood.V84.7.2221.2221","article-title":"Lymphocyte depletion during treatment with intensive chemotherapy for cancer","volume":"84","author":"Mackall","year":"1994","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.jare.2023.04.001_b0105","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/bloodadvances.2020001797","article-title":"Lingering effects of chemotherapy on mature T cells impair proliferation","volume":"4","author":"Das","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jare.2023.04.001_b0110","first-page":"1481","article-title":"Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer","volume":"35","author":"Onyema","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jare.2023.04.001_b0115","article-title":"Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma","author":"Kam","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jare.2023.04.001_b0120","article-title":"Mechanisms regulating T-cell infiltration and activity in solid tumors","author":"Lanitis","year":"2017281218","journal-title":"Ann Oncol"},{"issue":"7637","key":"10.1016\/j.jare.2023.04.001_b0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jare.2023.04.001_b0130","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.immuni.2013.05.009","article-title":"Effector-like CD8(+) T cells in the memory population mediate potent protective immunity","volume":"38","author":"Olson","year":"2013","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jare.2023.04.001_b0135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/CJI.0b013e31827806e6","article-title":"Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?","volume":"35","author":"Klebanoff","year":"2012","journal-title":"J Immunother"},{"issue":"3","key":"10.1016\/j.jare.2023.04.001_b0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat Immunol"},{"issue":"Pt 2","key":"10.1016\/j.jare.2023.04.001_b0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semcancer.2018.02.010","article-title":"Genomics and emerging biomarkers for immunotherapy of colorectal cancer","volume":"52","author":"Kather","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.jare.2023.04.001_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030420","article-title":"Engagement with tNOX (ENOX2) to Inhibit SIRT1 and Activate p53-Dependent and -Independent Apoptotic Pathways by Novel 4,11-Diaminoanthra[2,3-b]furan-5,10-diones in Hepatocellular Carcinoma Cells","volume":"11","author":"Lin","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.jare.2023.04.001_b0155","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1158\/0008-5472.CAN-11-0268","article-title":"Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy","volume":"71","author":"Halama","year":"2011","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.jare.2023.04.001_b0160","doi-asserted-by":"crossref","first-page":"e1005219","DOI":"10.1371\/journal.ppat.1005219","article-title":"Phenotypic and Functional Alterations in Circulating Memory CD8 T Cells with Time after Primary Infection","volume":"11","author":"Martin","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jare.2023.04.001_b0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-540-69184-6_6","article-title":"Granule-mediated cytotoxicity","volume":"23","author":"Darmon","year":"1999","journal-title":"Results Probl Cell Differ"},{"issue":"15","key":"10.1016\/j.jare.2023.04.001_b0170","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1074\/jbc.M009038200","article-title":"Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway","volume":"276","author":"Pinkoski","year":"2001","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jare.2023.04.001_b0175","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cell.2015.03.031","article-title":"Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance","volume":"161","author":"Steinert","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.jare.2023.04.001_b0180","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ni.2714","article-title":"Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen","volume":"14","author":"Doedens","year":"2013","journal-title":"Nat Immunol"},{"issue":"13","key":"10.1016\/j.jare.2023.04.001_b0185","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1084\/jem.20112607","article-title":"PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells","volume":"209","author":"Finlay","year":"2012","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.jare.2023.04.001_b0190","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","article-title":"An HIF-1alpha\/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression","volume":"32","author":"Palazon","year":"2017","journal-title":"Cancer Cell"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123223000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123223000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:56:54Z","timestamp":1761857814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123223000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":38,"alternative-id":["S2090123223000930"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2023.04.001","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ENOX2 inhibition enhances infiltration of effector memory T-cell and mediates response to chemotherapy in immune-quiescent nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2023.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}